Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm, Two Phase, Multicenter Clinical Trial to Evaluating the Efficacy and Safety of the CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma

NCT02728882 is registered in ClinicalTrials.gov with Sinobioway Cell Therapy Co., Ltd. as lead sponsor.

NCT NCT02728882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02728882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm, Two Phase, Multicenter Clinical Trial to Evaluating the Efficacy and Safety of the CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma
Lead sponsor
Sinobioway Cell Therapy Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
July 2, 2015
Completion date
July 31, 2019
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma